olmesartan medoxomil has been researched along with Cardiac Failure in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Terra, SG | 1 |
| Hori, M; Mano, T; Masuyama, T; Miwa, T; Nishikawa, N; Nishio, M; Ohtani, T; Sakata, Y; Yamamoto, K; Yoshida, J | 1 |
| Fujita, M; Hirata, A; Hori, M; Kitakaze, M; Liao, Y; Minamino, T; Nagamachi, Y; Nakatani, T; Ogawa, S; Okada, K; Ozawa, K; Takashima, S; Tomoike, H; Tsukamoto, O; Tsukamoto, Y; Yutani, C | 1 |
| Hasegawa, K; Kishimoto, C; Kita, T; Nimata, M; Okabe, TA; Shioji, K; Yuan, Z | 1 |
| Gong, G; Hu, Q; Ishibashi, Y; Lee, J; Liu, J; Mansoor, A; Murakami, Y; Ochiai, K; Shimada, T; Wang, X; Zhang, J | 1 |
5 other study(ies) available for olmesartan medoxomil and Cardiac Failure
| Article | Year |
|---|---|
Cardiology patient page. Angiotensin receptor blockers.
Topics: Acrylates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Diuretics; Dizziness; Drug Combinations; Drug Interactions; Heart Failure; Humans; Hypertension; Imidazoles; Irbesartan; Kidney Diseases; Losartan; Olmesartan Medoxomil; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan | 2003 |
AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium-Binding Proteins; Calcium-Transporting ATPases; Diastole; Disease Progression; Drug Therapy, Combination; Extracellular Matrix; Heart Failure; Heart Ventricles; Hemodynamics; Hypertension; Imidazoles; Inflammation; Male; Olmesartan Medoxomil; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Tetrazoles; Thiazepines; Ventricular Dysfunction, Left | 2004 |
Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Valve Stenosis; Apoptosis; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Disease Progression; Endoplasmic Reticulum; Gene Expression Regulation; Heart Failure; Humans; Imidazoles; Ligation; Male; Mice; Mice, Inbred C57BL; Molecular Chaperones; Myocytes, Cardiac; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Rats; Rats, Inbred WKY; RNA, Messenger; Signal Transduction; Stress, Physiological; Tetrazoles; Thapsigargin; Tunicamycin | 2004 |
Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Autoimmune Diseases; Blood Pressure; Body Weight; Cardiomyopathies; Disease Models, Animal; Heart Failure; Heart Rate; Imidazoles; Interleukin-1; Lymphocytes; Myocarditis; Myocardium; Myosins; Olmesartan Medoxomil; Organ Size; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Tetrazoles | 2005 |
Functional and bioenergetic consequences of AT1 antagonist olmesartan medoxomil in hearts with postinfarction LV remodeling.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Coronary Vessels; Energy Metabolism; Heart; Heart Failure; Imidazoles; Magnetic Resonance Spectroscopy; Mitochondria; Myocardial Infarction; Olmesartan Medoxomil; Oxygen Consumption; Phosphates; Proton-Translocating ATPases; Renin-Angiotensin System; Swine; Tetrazoles; Ventricular Remodeling | 2006 |